Clinical trial
Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
NCT07224490 is registered in ClinicalTrials.gov with Stephanie B. Seminara, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease
- Lead sponsor
- Stephanie B. Seminara, MD
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- March 10, 2026
- Completion date
- May 31, 2030
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
long covid, neurodegeneration, reproductive disorder, sars-cov 2